Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Innovation Stock A fund, which has shown a recent decline in net value but positive returns over various time frames [1] - As of May 23, 2025, the latest net value of the fund is 1.2814 yuan, reflecting a decrease of 1.07% [1] - The fund's one-month return is 5.81%, ranking 28 out of 1022 in its category, while the six-month return is 22.29%, ranking 32 out of 984, and the year-to-date return is 23.24%, ranking 30 out of 999 [1] Group 2 - The top ten holdings of the China Europe Medical Innovation Stock A fund account for a total of 75.62%, with the largest positions in WuXi AppTec (10.35%), Kelun-Biotech (10.15%), WuXi Biologics (9.82%), and WuXi AppTec (9.60%) [1] - The fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 4.675 billion yuan [1] - The fund manager is Ms. Ge Lan, who has extensive experience in the investment management field, having joined China Europe Fund Management in October 2014 [2]
5月23日中欧医疗创新股票A净值下跌1.07%，近1个月累计上涨5.81%
Sou Hu Cai Jing·2025-05-23 14:41